Keyphrases
Clinical Response
100%
Inflammatory Bowel Disease
100%
Steroid-free Remission
100%
Upadacitinib
100%
Ulcerative Colitis
50%
Pediatric Ulcerative Colitis
37%
Clinical Remission
25%
Steroid-free
25%
C-reactive Protein
25%
Safety Signal
25%
Calprotectin
25%
Pediatric Crohn's Disease Activity Index
25%
Pediatric
12%
Children's Hospital
12%
Therapeutic Potential
12%
Remission
12%
Adverse Events
12%
Mucosal Response
12%
Endoscopic Score
12%
Single Center
12%
Endoscopic Remission
12%
Retrospective Cohort
12%
Endoscopic Response
12%
Pediatric Subjects
12%
Subtotal Colectomy
12%
Janus Kinase Inhibitors
12%
Downtrend
12%
Label Use
12%
Diverting Ileostomy
12%
Inflammatory Bowel Disease Unclassified
12%
Rectal Stricture
12%
Rectal Perforation
12%
Medicine and Dentistry
Inflammatory Bowel Disease
100%
Upadacitinib
100%
Ulcerative Colitis
87%
Pediatrics
87%
Crohn's Disease Activity Index
25%
C Reactive Protein
25%
Calgranulin
25%
Adverse Event
12%
Stricture
12%
Patient with Inflammatory Bowel Disease
12%
Colectomy
12%
Ileostomy
12%
Janus Kinase Inhibitor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Remission
100%
Inflammatory Bowel Disease
100%
Upadacitinib
100%
Ulcerative Colitis
77%
Disease Activity
22%
Calgranulin
22%
C Reactive Protein
22%
Crohn's Disease
22%
Adverse Event
11%
Janus Kinase Inhibitor
11%